Atriva Therapeutics GmbH
Records under this name other than the patents Atriva Therapeutics GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to Atriva Therapeutics GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,135,263 | Novel-Anti-Infective Strategy Against Influenza Virus and S. Aureus Coinfections Lapsed on the fee record Ended Oct 5, 2025 · Low confidence | Lapsed on the fee record | Ended Oct 5, 2025 | Low confidence |
| US 9,566,281 | MEK inhibitors in the treatment of virus diseases Lapsed on the fee record Ended Feb 14, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 14, 2025 | USPTO record |